Europe Orthopedic Knee Market, By Product Type (Knee Arthroscopy, Ligament Repair, and Others), Indication (Osteoarthritis, Cruciate and Collateral Ligament Tears, Meniscal Injuries, and Others), End-User (Hospitals, Rehabilitation Centers, Orthopedic Centers, Ambulatory Surgical Centres, and Others) - Industry Trends and Forecast to 2029.
Market Analysis and Insights
The knee is the largest joint in the body. The upper and lower bones of the knee are separated by two discs (menisci). The upper leg bone (femur) and the lower leg bones (tibia and fibula) are connected by ligaments and tendons. Several reasons are presented, which necessitate the use of orthopedic knee instruments such as knee implants, orthoses, and aids and the use of medications such as analgesics and non-steroidal anti-inflammatory drugs (NSAIDs). The common reason for knee replacement surgery is to relieve severe pain caused by osteoarthritis, crucial and collateral ligament tears, and meniscal injuries. People who require knee replacement surgery usually have problems walking, climbing stairs, and getting in and out of chairs. Some also have knee pain at rest.
Market Definition
In Europe, orthopedic diseases continue to rise throughout the globe. The common knee disease which occurs in Europe is knee osteoarthritis. Knee osteoarthritis accounts for almost four-fifths of the burden of osteoarthritis (OA) worldwide and increases with obesity and age. Knee diseases, especially knee osteoarthritis, are common and a major cause of disability among the elderly population. Up to now, knee osteoarthritis has shown to be curable except, for knee arthroplasty which is considered an effective treatment at an advanced stage of the disease. The knee arthroplasty surgery involves incision and removal of the damaged bone from the thighbone of the patient and knee cap and replacing it with artificial joint (prosthesis and implants), which are mobile and fixed bearing implants. The prosthesis and implants are composed of metal, ceramic, and plastic. The ligaments are repaired by placing them back onto the original bone in their anatomic position, by using a small anchor to attach the ligaments to the bone.
Data Bridge Market Research analyses that the Europe orthopedic knee market will grow at a CAGR of 5.0% during the forecast period of 2022 to 2029.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Million, Pricing in USD
|
|
Segments Covered
|
By Product Type (Knee Arthroscopy, Ligament Repair and Others), Indication (Osteoarthritis, Cruciate and Collateral Ligament Tears, Meniscal Injuries and Others), End User (Hospitals, Rehabilitation Centers, Orthopedic Centers, Ambulatory Surgical Centers and Others), Country (Germany, France, U.K., Spain, Italy, Turkey, Netherlands, Belgium, Switzerland and Rest of Europe)
|
|
Region Covered
|
Europe
|
|
Market Players Covered
|
Smith & Nephew, Össur, OTTOBOCK, DePuy Synthes (A subsidiary of Johnson & Johnson Private Limited), GROUP FH ORTHO, Stryker, Zimmer Biomet., B. Braun Melsungen AG, aap Implantate AG, MicroPort Orthopedics, Inc., Exactech, Inc., Medacta International, Aequos Endoprothetik GmbH, Symbios Orthopédie S.A., PETER BREHM GmbH, Bayer AG, alloPlus GmbH, Bauerfeind USA Inc., amplitude SURGICAL and CERAVER
|
Europe Orthopedic Knee Market Dynamics
Drivers
- Rise in incidence of knee diseases
Orthopedic diseases continue to rise throughout the globe. The typical knee disease which occurs in Europe is knee osteoarthritis. Knee osteoarthritis accounts for almost four-fifths of osteoarthritis (OA) burden worldwide and increases with obesity and age. Knee diseases, especially knee osteoarthritis, are common and a significant cause of disability among the elderly population. Knee osteoarthritis can be treated easily in Europe. In Europe, a survey conducted by e-clinical medicine states that the prevalence of knee diseases in Europe was 19.2%.
For instance,
- In March 2020, according to a report by the Oxford Academic, the incidence of knee osteoarthritis was reported to show the highest number of cases in the U.K., followed by France, Germany, Spain, and Italy, showing the fewer record cases of knee osteoarthritis
Knee osteoarthritis is a common occurrence in Switzerland. The rise in the incidence of chronic knee disorders is expected to boost the sales and supply of medication and implants for the treatment of knees in Europe. It is expected to meet the patient's requirements. The knowledge about the prevalence and incidence of orthopedic knee diseases would help find novel solutions and aid in more collaborations and partnerships with market players based in countries in Europe.
- Rise in awareness about knee treatment in Europe
Cognizance of knee disorders, understanding, and scope of the treatment is a vital step to help and guide people suffering from osteoarthritis and meniscal injuries. It helps in achieving early detection and management. Public and private institutes' awareness about the symptoms and treatment of chronic knee diseases would result in timely treatment and provide the option to access inexpensive universal health aid and increased availability of rehabilitative therapy
For instance,
- In November 2020, the European Knee Society (EKS) had collaborated with the Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Italy, for organizing two fellowships and creating awareness about the treatment of primary and revision knee and hip replacement
From the above points, we can establish that awareness about the early treatment and use of knee implants would result in collaborations of market players with health institutions for the supply and distribution of the devices. This will result in a rise in product and business line expansion.
Opportunities
- Strategic Initiatives By Market Players
The need for medications to treat knee disorders in Europe has increased due to the rise in prevalence and incidence of chronic knee disorders, advanced therapies for knee osteoarthritis and meniscal injuries, and unmet medical needs. The factors (such as rise in incidence, cases of chronic knee disorders, and availability of advanced therapies) enhance the necessity for orthopedic rehabilitation therapy, and to achieve the market demand, minor and major market players are utilizing various strategies.
The major players are also trying to devise specific strategies, such as product launches, acquisitions, approvals, expansions, and partnerships, to ensure the smooth running of the business, avoid risks, and increase the long-term growth in the sales of the market.
For instance,
- In June 2020, Zimmer Biomet received clearance from the Food and Drug Administration (FDA) for ROSA Hip System for Robotically-Assisted Direct Anterior Total Hip Arthroplasty. The clearance received had made the ROSA Hip System available for use by diagnostic centers in Europe and made it clear for post-marketing approval
- In December 2017, amplitude SURGICAL launched the ACLip, an innovation in anterior cruciate ligament (ACL) reconstruction knee surgery. The ACLip is a knee implant that provides surgeons an enhanced method to perform knee arthroscopy surgeries and is used as an outpatient procedure. The launch had increased the sales and revenue of the knee product segment, and the novel implant was distributed in orthopedic clinics in Europe
The growth of technological advancements in orthopedic knee implants
Total knee arthroplasty is a suitable treatment for severe osteoarthritis. Despite reasonable survival rates, up to 20% of real knee arthroplasty patients remain dissatisfied. Recently, promising new technologies have been developed in knee arthroplasty and could improve functional outcomes. The robotic-assisted systems allow an accurate and reproducible bone preparation due to robotic assistance, with a 3D surgical planning, based on preoperative 3D imaging or not.
For instance,
- In November 2021, Smith & Nephew launched the turnkey' robotic-assisted surgical system; an advanced system for total and partial knee arthroplasties. The turnkey robotic surgical system was designed to measure, plan, and perform a knee surgery that is personalized to the patient's anatomy
Novel technologies are expected to improve diagnosis, risk stratification, and disease monitoring of meniscal injuries and osteoarthritis. The innovative combined drug therapies are expected to improve patient outcomes in the coming years. Hence, the use of innovative treatments is expected to create lucrative opportunities for the Europe orthopedic knee market
Restraints/Challenges
• Problems Faced While Using Orthopedic Knee Medications and Implants
Orthopedic specialists observe certain risks while using the implants and consuming the medications. The knee replacement surgeries deliver complications that arise from surgery or a faulty implant. The implant becoming loose is one of the most severe complications after knee surgery, and pain is the most common one. Loosening can cause bone fractures, instability, and serious falls. Almost all serious complications require revision surgery. The risks faced are mechanical risks, knee implant loosening and physical pain.
For instance,
- The risks incurred while using the orthopedic ceramic knee implants are implant failure due to induced aseptic loosening and hypersensitivity
- The complications occurred in metal implants after surgery are loosening, instability, dislocation, misalignment, and device failure, which can result from manufacturing defects, poorly fitted implants, or problems during surgery
The risks that occur while using the knee implants and consuming the medication would decrease the usage and supply of the knee implants and bracing and supporting devices. This may lead to a decline in sales of implants and drugs. Therefore, the risks related to knee medications and implants are expected to hinder the market growth.
- Lack of skilled professionals
The lack or shortage of skilled expertise would challenge the pace of recovery and growth in one place. Often, the unemployed people in one place have skills that are in short supply elsewhere. Moreover, rapid technological advancement in this field also leads to a lack of expertise. Despite the call to increase, the number of podiatrists in Europe and several residency training programs remain unknown.
For instance,
- In England, the data by the National Center of Biotechnology Information (NCBI) state that joint arthroplasty service has substantially declined over recent weeks throughout Europe
As skill demands are too high, it has manifested as a challenge to retain and manage skill-specified professionals. Moreover, technological advancement is another aspect that leads to the increased demand for skilled professionals
The Europe orthopedic knee market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Europe orthopedic knee market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
The data by the Academic coup states that around four million people suffer from knee osteoarthritis, across Europe and has a lifetime risk of 45% for knee osteoarthritis.
Europe orthopedic knee market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on the Europe Orthopedic Knee Market
The COVID-19 has negatively affected the market. Lockdowns and isolation during pandemics complicate the diagnosis management and treatment. The lack of access to orthopaedic clinics will further affect the market. Social isolation increases stress, despair, and social support, all of which may cause a reduction in the treatment of chronic knee injuries during the pandemic.
Recent Development
- In March, DePuy Synthes had added two more orthopedic knee products in its portfolio, to the Attune knee portfolio, during the pandemic. The two products which were added are the cementless fixed bearing knee and medial stabilized knee to it’s attune knee portfolio. The addition of the new orthopedic knee products increased the product segment revenue and increased the market size in Europe region
Europe Orthopedic Knee Market Scope
The Europe orthopedic knee market is segmented on the basis of product type, indication and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Knee arthroscopy
- Ligament Repair
- Others
On the basis of product type, the market is segmented into knee arthroscopy, ligament repair and others.
Indication
- Osteoarthritis
- Cruciate And Collateral Ligament Tears
- Meniscal Injuries
- Others
On the basis of indication, the market segmented into osteoarthritis, cruciate and collateral ligament tears, meniscal injuries and others
End User
- Hospitals
- Rehabilitation Centers
- Orthopedic Centers
- Ambulatory Surgical Centers
- Others
On the basis of end user, the market is segmented into hospitals, rehabilitation centers, orthopedic centers, ambulatory surgical centers and others.
Europe Orthopedic Knee Market Regional Analysis/Insights
The Europe orthopedic knee market is analysed and market size insights and trends are provided by country, product type, indication and end user, as referenced above.
The countries covered in the Europe orthopedic knee market report are Germany, France, U.K., Spain, Italy, Turkey, Netherlands, Belgium, Switzerland and Rest of Europe. Germany is expected to dominate the market due to rise in knee osteoarthritis, rise in knee arthroplasty surgeries and presence of various orthopedic centers in Germany.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are Considered While Providing Forecast Analysis of the country data.
Competitive Landscape and Europe Orthopedic Knee Market Share Analysis
The Europe orthopedic knee market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, the global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the Europe orthopedic knee market.
Some of the major players operating in the Europe orthopedic knee market are Smith & Nephew, Össur, OTTOBOCK, DePuy Synthes (A subsidiary of Johnson & Johnson Private Limited), GROUP FH ORTHO, Stryker, Zimmer Biomet., B. Braun Melsungen AG, aap Implantate AG, MicroPort Orthopedics, Inc., Exactech, Inc., Medacta International, Aequos Endoprothetik GmbH, Symbios Orthopédie S.A., PETER BREHM GmbH, Bayer AG, alloPlus GmbH, Bauerfeind USA Inc., amplitude SURGICAL and CERAVER among others.
SKU-